About the Esophageal Adenocarcinoma Session
Esophageal adenocarcinoma (EAC) is a malignant tumor that originates in the cells lining the esophagus, the muscular tube that connects the throat to the stomach. Despite being relatively uncommon, EAC represents a significant health concern due to its aggressive nature and poor prognosis. Cancer research in this field aims to elucidate the underlying molecular mechanisms driving EAC development, identify biomarkers for early detection, and discover targeted therapies for more effective treatment. Recent advancements include the exploration of immunotherapies, such as checkpoint inhibitors, and the investigation of novel targeted agents aimed at specific genetic alterations frequently found in EAC. Additionally, efforts are directed towards understanding the role of lifestyle factors, such as obesity and gastroesophageal reflux disease, in EAC development, paving the way for preventive strategies and personalized treatment approaches.
Topics Covered in Esophageal Adenocarcinoma
Intestinal Metaplasia
Reflux & Obesity
Dysplasia Surveillance
Endoscopic Eradication
Neoadjuvant Therapy
Checkpoint Inhibitors
Related Scientific Sessions at CIOC 2027
Why Attend the Esophageal Adenocarcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Esophageal Adenocarcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Esophageal Adenocarcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Esophageal Adenocarcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Esophageal Adenocarcinoma Conference 2027 — FAQs
What is the Esophageal Adenocarcinoma track at CIOC 2027?
The Esophageal Adenocarcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Esophageal Adenocarcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Esophageal Adenocarcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Esophageal Adenocarcinoma are all welcome — whether presenting or attending.
Can I present my research in the Esophageal Adenocarcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Esophageal Adenocarcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Esophageal Adenocarcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.